Guideline for Preoperative Medication Management
Guideline: Preoperative Medication Management
Guideline for Preoperative Medication Management
Purpose of Guideline: To provide guidance to physicians, advanced practice providers (APPs),
pharmacists, and nurses regarding medication management in the preoperative setting.
Background:
Appropriate perioperative medication management is essential to ensure positive surgical
outcomes and prevent medication misadventures.1 Results from a prospective analysis of 1,025
patients admitted to a general surgical unit concluded that patients on at least one medication
for a chronic disease are 2.7 times more likely to experience surgical complications compared
with those not taking any medications. As the aging population requires more medication use and
the availability of various nonprescription medications continues to increase, so does the risk of
polypharmacy and the need for perioperative medication guidance.2
There are no well-designed trials to support evidence-based recommendations for perioperative
medication management; however, general principles and best practice approaches are available.
General considerations for perioperative medication management include a thorough medication
history, understanding of the medication pharmacokinetics and potential for withdrawal
symptoms, understanding the risks associated with the surgical procedure and the risks of
medication discontinuation based on the intended indication.
Clinical judgement must be exercised, especially if medication pharmacokinetics are not
predictable or there are significant risks associated with inappropriate medication withdrawal (eg,
tolerance) or continuation (eg, postsurgical infection).2
Clinical Assessment:
Prior to instructing the patient on preoperative medication management, completion of a thorough
medication history is recommended ¨C including all information on prescription medications, over-the-counter
medications, ¡°as needed¡± medications, vitamins, supplements, and herbal medications. Allergies should also
be verified and documented.
The following recommendations are intended as guidelines and not intended to replace clinical judgement,
provider discretion, or special circumstances. Please consider a discussion with surgeon and or
anesthesiologist for situations where one may deviate from the guideline. Examples for pharmacologic
classes are not all inclusive so providers should review the drug class for any new additions or unlisted
medications. If there are any combination products, you should reference each medication separately.
1
Guideline: Preoperative Medication Management
Quick Guide for Preoperative Medication Management
Medication Class
Examples
CONTINUE up to and including the day of surgery:
Alpha1 Blockers
Doxazosin, prazosin, tamsulosin
Alpha2 Agonists
Clonidine, guanfacine, methyldopa
Antianxiety Agents
Alprazolam, buspirone, clonazepam
Antiarrhythmics
Amiodarone, digoxin, sotalol
Anticholinergics (inhaled)
Ipratropium, tiotropium
Anticholinesterase Inhibitors
Donepezil, memantine, rivastigmine
Antidepressants
Bupropion, fluoxetine, sertraline
Antiepileptic Agents
Carbamazepime, levetiracetam, phenytoin
Antigout Agents
Allopurinol, colchicine, febuxostat
Antihistamines
Cetirizine, fexofenadine, loratadine
Antipsychotics
Haloperidol, lurasidone, olanzapine
Antiretroviral/antivirals
Abacavir, tenofovir, valacyclovir
Antispasmodic Agents
Oxybutynin, tolterodine
Aromatase Inhibitors
Anastrozole, exemestane, letrozole
Beta Blockers
Atenolol, carvedilol, metoprolol, propranolol
Beta2 Agonists (inhaled)
Albuterol, salmeterol
Calcium Channel Blockers
Amlodipine, diltiazem, verapamil
Combined Oral Contraceptives
Estrogen and progestin components
Dopamine Agonists/ Anti-Parkinson
Amantadine, carbidopa/levodopa, entacapone
Agents
GABA Agonists
Gabapentin, pregabalin
Glucocorticoids (systemic, inhaled)
Budesonide, fluticasone, prednisone
H2 Receptor Blockers
Cimetidine, famotidine, ranitidine
HMG-CoA Reductase Inhibitors
Atorvastatin, rosuvastatin, simvastatin
Leukotriene Inhibitors
Montelukast, zafirlukast
Mood Stabilizers
Lithium, valproic acid
Nitric Oxide/Vasodilators
Hydralazine, isosorbide, nitroglycerin
Opioids
Codeine, hydromorphone, morphine, tramadol
OTC Analgesics
Acetaminophen
OTC eye drops and nasal sprays
Artificial tears, saline nasal spray
Proton Pump Inhibitors
Esomeprazole, omeprazole, pantoprazole
Skeletal Muscle Relaxants
Baclofen, cyclobenzaprine, tizanidine
Thyroid Agents
Levothyroxine, methimazole, PTU
DISCONTINUE these medications one day prior to procedure:
Antimigraine Agents
Eletriptan, rizatriptan, sumatriptan
Non-statin Lipid Lowering Agents
Cholestyramine, ezetimibe, fenofibrate
Theophylline
Theophylline
DISCONTINUE these medications on the day of procedure:
ACE/ARB
Enalapril, lisinopril, losartan, valsartan
Direct Renin Inhibitors
Aliskiren
Diuretics
Furosemide, hydrochlorothiazide
MEDICATIONS WITH SPECIAL CONSIDERATIONS (see page for more information):
Aminosalicylates
Sulfasalazine, mesalamine
Bisphosphonates
Alendronate, ibandronate, zoledronic acid
Immunosuppressants and Antirheumatic Appendix A
2
Page Number
4, 7
4
5
4
6
5
6
5
7
7
5, 6
4
7
5
4
6
4
5
5
4
5, 7
5
4
7
6
4
4
4
7
5
4
5
7
7
7
7
7
8
8
8
9, 12
Guideline: Preoperative Medication Management
Agents
Insulin
Opioid Agonists-Antagonists/
Antagonists
Oral Antidiabetic Agents
Detemir, glargine, lispro
Buprenorphine, buprenorphine-naloxone,
naltrexone
Canagliflozin, metformin, glyburide
Oral Chemotherapy
Post-menopausal Hormone Therapy
Selective Estrogen Receptor Modulators
MEDICATIONS AFFECTING HEMOSTASIS:
Anticoagulants
Antiplatelet Medications
Aspirin
NSAIDs
Phosphodiesterase-5 Inhibitors
Stimulants/Anti-ADHD Agents
Vitamins and Supplements
Weight loss/CNS Stimulants
9
8
9,14
Capecitabine, imatinib, sunitinib
Estrogens
Raloxifene, tamoxifen
Apixaban, enoxaparin, heparin, warfarin
Cilostazol, clopidogrel, prasugrel
Aspirin
Ibuprofen, naproxen
Sildenafil, tadalafil
Dextroamphetamine, methylphenidate
Vitamins, herbals and supplements
Phentermine
APPENDICES
Appendix A: Immunosuppressant and Antirheumatic Agents
Appendix B: Monoamine Oxidase Inhibitors and Herbals
Appendix C: Management of Patients with Diabetes
Appendix D: Management of NSAIDs and Antiplatelet Agents
SUPPLEMENTAL INFORMATION
9
8
8
10
10
10
10
11
11
11
11
12
13
14, 15
16
Additional information can be found by accessing institutional and national guidelines listed below.
- Anticoagulation Management Homepage
- Breast Cancer Seed/Wire Anticoagulation Process
- Buprenorphine Recommendations for Perioperative Management (Guideline under ¡°Pain
Management¡±)
- Institutional Antiplatelet Algorithm (September 2016 Update) (under ¡°Cardiovascular¡± section)
- Management of Anticoagulant Medications in the Periprocedural and Surgical Settings
- Ophthalmology Antithrombotic Management Protocol
- Preoperative Resources Homepage
- Use of Antithrombotic Medications in the Presence of Neuraxial Anesthesia
3
Guideline: Preoperative Medication Management
CONTINUE THESE MEDICATIONS UP TO AND INCLUDING THE DAY OF PROCEDURE:
(Instruct patients to take with a small sip of water)
ANALGESICS (PAIN) AGENTS
Class
GABA Agonists3,4
Examples
Gabapentin, pregabalin
Opioids5,6,7
Codeine, fentanyl, hydromorphone,
morphine, oxycodone, hydrocodone
(including combination products),
tramadol
Acetaminophen
Over the Counter
Analgesics5
Skeletal Muscle
Relaxants5
Baclofen, cyclobenzaprine,
metaxalone, methocarbamol,
tizanidine
This class also includes benzodiazepines such as
alprazolam, clonazepam and diazepam
CARDIOVASCULAR AGENTS
Class
Alpha1 Blockers
Examples
Terazosin, prazosin
Alpha2 Agonists5,9
Antiarrhythmic Agents5
Beta Blockers5,10,11
Considerations
Also see urinary agents for more information
Clonidine, guanfacine,
methyldopa
Amiodarone, digoxin,
dofetilide, dronedarone,
flecainide, sotalol
Atenolol, carvedilol,
metoprolol, labetalol,
propranolol
Calcium Channel Blockers
(CCB)5
HMG-CoA Reductase
Inhibitors (Statins)5,9,11
Amlodipine, diltiazem,
verapamil, nifedipine
Atorvastatin, pravastatin,
simvastatin, rosuvastatin
Nitric
Oxide/Vasodilators12,13
Hydralazine, isosorbide
dinitrate, isosorbide
mononitrate, minoxidil,
nitroglycerin (all
formulations)
ANTIRETROVIRAL/ANTIVIRAL AGENTS5,8
Class
Antiretrovirals
Antivirals
Considerations
These agents may be used to treat neuropathic
pain
DEFER TO ANESTHESIA, CHRONIC PROVIDER,
SURGEON AND PRE-OPERATIVE CLINIC
PROVIDER
Examples
Abacavir, dolutegravir, efavirenz,
emtricitabine, lamivudine, ritonavir,
tenofovir
Acyclovir, famciclovir, valacyclovir
4
EXCEPTION: Patients going for Stage 1 Deep
brain stimulation (DBS) for treatment of
tremor and who are taking beta blockers for
the treatment of tremor should DISCONTINUE
on day of surgery, if any questions regarding
these instructions contact Neurosurgeon and
prescribing physician
Considerations
This list is not all-encompassing
Guideline: Preoperative Medication Management
ENDOCRINE AGENTS
Class
Aromatase
Inhibitors5
Examples
Anastrozole, exemestane, letrozole
Combined Oral
Contraceptives (ie,
Estrogencontaining)5
Glucocorticoids
(Systemic)5,14
Thyroid Agents5
Budesonide, dexamethasone,
hydrocortisone,
methylprednisolone, prednisolone,
prednisone
Levothyroxine, methimazole,
propylthiouracil
GASTROINTESTINAL AGENTS
Class
H2 Receptor
Blockers5
Examples
Cimetidine*, Famotidine, Ranitidine
Proton Pump
Inhibitors5
Esomeprazole, lansoprazole,
omeprazole, pantoprazole,
rabeprazole
NEUROMUSCULAR AGENTS
Class
Anticholinesterase
Inhibitors17
Antiepileptic
Agents17
Dopamine Agonists
and Other AntiParkinson
Agents13,17
Considerations
Consider risk of thromboembolism versus
benefits of pregnancy prevention. Combined
oral contraceptives may be continued in
women with moderate to high risk of
thromboembolism who could have difficulty
complying with other forms of contraception.
If the choice is made to discontinue, consider
discontinuing 4 to 6 weeks prior to surgery.
Considerations
*
May continue especially if risk for
gastrointestinal ulcers or bleeding is high,
however, monitor for potential drug
interactions as cimetidine can alter the
metabolism of several drugs5
Examples
Donepezil, memantine,
pyridostigmine, galantamine,
rivastigmine
Carbamazepine, levetiracetam,
phenytoin, valproic acid
Considerations
These agents may be used for the treatment
of Alzheimer disease or myasthenia gravis
Amantadine, carbidopa/levodopa,
entacapone
EXCEPTION: Patients going for Stage 1 DBS
should DISCONTINUE these medications on
day of surgery.
PSYCHOTROPIC AGENTS
Class*
Antianxiety agents
and
Benzodiazepines5
Antipsychotics5
Generic (Brand) Examples
Considerations
Alprazolam, clonazepam, diazepam,
lorazepam, temazepam, buspirone
Haloperidol, lurasidone, olanzapine, Obtain baseline ECG if none available within
risperidone, ziprasidone
the last 3 months. Use caution if these
agents are combined with other QT
5
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- atorvastatin pfizer medsafe
- patient information atorvastatin calcium a tor va stat in lannett
- guideline for preoperative medication management
- entresto medsafe
- patient information sun pharma
- if you take more atorvastatin than you should reporting of side effects
- how to use statins in patients with chronic liver disease
- patient information do not keep medicine that is out of date or that
- oral dosage forms that should not be crushed 2016 institute for safe
- when you must not take it pfizer before you take atorvastatin taking
Related searches
- guideline for isolation precautions cdc 2019
- cdc guideline for isolation precautions
- fha guideline for future employment
- icd 10 medication management 10
- icd 10 for preoperative covid test
- joint commission medication management chapter
- tjc medication management standards 2019
- 2017 aha guideline for hypertension
- cms guidelines for preoperative h p
- encounter medication management icd 10
- cms guideline for telehealth
- poverty guideline for family of 2